Clinical trials: Post-operative Nausea and Vomiting

Postoperative Nausea and Vomiting

Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

To assess the efficacy and safety of different doses of APD405 in the prevention of post-operative nausea and vomiting (PONV) in adult patients at moderate to high-risk of PONV.

Trial name

NCT00895830

Testing

APD405

Where

18 sites in United States, France and 2 more

Volunteers

257 people

Sponsor

Acacia Pharma Ltd